Ilkka Kantola
0000-0002-6228-522X
Publication & Citation Trends
Publications
0 total
Do we need lyso Gb3 measurement in monitoring Fabry disease?
Cited by 0
Semantic Scholar
Genetics, cardiac phenotype and cardiovascular outcomes in Fabry disease patients in Finland
Cited by 0
Semantic Scholar
Impact of Proteinuria on Renal Outcomes in the BALANCE Trial
Cited by 0
Semantic Scholar
Hemodynamic Bedside Monitoring Instrument with Pressure and Optical Sensors: Validation and Modality Comparison
Cited by 7
Semantic Scholar
Aging Fabry disease patients
Cited by 0
Semantic Scholar
Clinical outcomes in patients switching from agalsidase beta to migalastat: A Fabry Registry analysis OA
Cited by 9
Semantic Scholar
P005: Head-to-head trial of pegunigalsidase alfa vs agalsidase beta in Fabry disease: Phase 3 randomized, double-blind, BALANCE Study 2-year results OA
Cited by 0
Semantic Scholar
First results of a head-to-head trial of pegunigalsidase alfa vs. agalsidase beta in Fabry disease: 2 year results of the phase 3 randomized, double-blind, BALANCE study
Cited by 1
Semantic Scholar
Research Topics
Blood Pressure and Hypertension Studies
(89)
Lysosomal Storage Disorders Research
(53)
Cardiovascular Health and Disease Prevention
(34)
Heart Rate Variability and Autonomic Control
(24)
Sodium Intake and Health
(19)
Affiliations
Università Cattolica del Sacro Cuore
University of Iowa
Memorial University of Newfoundland
Apple (Israel)
Jichi Medical University